Associate Professor of Neurology, Duke University
Nipocalimab Shows Promise as Myasthenia Gravis Treatment: Jeffrey Guptill, MD, MS, MHS
The associate professor of neurology and neurologist at Duke University discussed the positive results of nipocalimab, a monoclonal antibody, in patients with myasthenia gravis.
CMSC Live: 2025 Annual Meeting Day 2
Remyelination in Multiple Sclerosis: Progress and Pipeline Updates
Survey Results Point to High Rates of Burnout Among APPs and Pharmacists in Neurology
Rebound Effect Not Observed With Multiple Sclerosis Therapy Ozanimod